Latest / Investor Exchange / Meta Health: 1Q2025 Quarterly Report

Transcript

Meta Health: 1Q2025 Quarterly Report · Investor Exchange

• 0:02
  Time for another Investor Exchange podcast. Here are your hosts, Matt and Sally.
• 0:08
  Welcome to the Deep Dive. We take a stack of documents, research,
• 0:11
  you name it, and pull up the key insights so you can get up to speed fast.
• 0:15
  We try to cut through the jargon, find those surprising details,
• 0:18
  and, well, keep things interesting.
• 0:21
  Today, we're digging into the latest numbers from MetaHealth Limited.
• 0:24
  And this isn't just, you know, your average quarterly update,
• 0:26
  it feels more like a snapshot of a company really in transition,
• 0:30
  facing some big hurdles, but also making some bold moves. That sums it up perfectly.
• 0:34
  The main source we're using here is their unaudited, condensed,
• 0:37
  interim consolidated financial statements, specifically for Q1,
• 0:42
  the three months ending March 31st, 2025.
• 0:45
  And there's some really important context right off the bat.
• 0:48
  This report is happening because their auditors in the previous year's financials
• 0:52
  for FY 2024 flagged a material uncertainty related to going concern.
• 0:58
  Right. That's a serious flag. So that definitely hangs over everything we're
• 1:01
  looking at today. It does. It adds weight to the numbers.
• 1:04
  So our mission today, let's unpack what these financials are really telling us about meta health.
• 1:09
  How do they actually perform? Why are the numbers shifting? And importantly,
• 1:13
  given that going concern note, what are they doing about it? What's their plan?
• 1:17
  And what do they see coming down the road? Okay, let's jump straight into that
• 1:20
  performance picture. The big number first, the bottom line.
• 1:23
  All right. So the headline figure is the overall loss for this period, Q1 2025.
• 1:27
  They reported a loss of about $0.3 million.
• 1:32
  Now, okay, it's still a loss. But compare that to the same three months in 2024.
• 1:36
  Their loss back then was $1.0 million. It's a massive change.
• 1:40
  It's a 67% reduction in their loss year on year for the quarter. 67 percent.
• 1:45
  Wow. OK, that's that's significant. How did they pull that off?
• 1:48
  Where did that improvement come from? Well, it's kind of a mix of things as usual.
• 1:52
  Let's start with revenue, the top line. OK, so focusing on their continuing
• 1:55
  operations, the stuff they're actually doing now, the revenue sought a really substantial increase.
• 2:00
  It jumped from just S. forty six thousand dollars in Q1 2024 all the way up
• 2:04
  to S. Three hundred twenty thousand dollars in Q1 2025.
• 2:08
  Hold on. S. Forty six thousand dollars.
• 2:11
  To S320,000 dollars. That's more than 100% increase, right? Much more.
• 2:16
  What happened there? Yeah, it's a huge leap. The report points directly to one main driver.
• 2:21
  It's the additional revenue from JAWS Medical Screening Center.
• 2:25
  That's the health screening business they bought back in early November 2024.
• 2:29
  So this Q1 is the first time we're seeing a full three months of its contribution.
• 2:35
  Ah, okay. So that acquisition is really starting to show up in the numbers now.
• 2:39
  Makes sense. It reflects that strategic shift they've been talking about moving
• 2:42
  into healthcare after selling off the metal business. Exactly.
• 2:45
  Bringing in that new operating business is clearly boosting the top line.
• 2:49
  Did anything else move on the income side, like other income?
• 2:52
  Other income actually went down, dropped from $35,000 last year to $7,000 this quarter.
• 2:57
  The explanation given is mainly fewer government grants received this time around.
• 3:01
  Got it. So the core business revenue really carried the load there,
• 3:04
  offsetting that dip in grants.
• 3:06
  Okay, let's flip to the other side expenses. What changed there?
• 3:09
  Did costs go up with the new revenue?
• 3:11
  Yes and no. It's a bit of a mixed picture, which is interesting.
• 3:15
  Some costs definitely went up tied directly to that new health center.
• 3:18
  For instance, raw materials and consumables used. They went up a bit.
• 3:23
  That lines up with doing more health screenings, more sales.
• 3:26
  Right. Variable costs expected.
• 3:28
  Then employee benefits expense. That saw a pretty big jump from $0.3 million to $0.4 million.
• 3:35
  That's up 46%. And they say that's directly because of the increased headcount
• 3:40
  and staff costs from bringing Joss Medical on board. More staff, higher payroll.
• 3:44
  Makes sense. And one more increase tied to the acquisition.
• 3:48
  Depreciation of right-of-use assets.
• 3:50
  That more than doubled. $7K is to $15K. Often these are linked to property leases,
• 3:54
  so likely the lease for the JAWS medical facility.
• 3:57
  Again, tracks back to the acquisition. Okay, so the acquisition drove revenue
• 4:00
  up, but it also brought expected increases in direct costs, staff,
• 4:04
  materials, leases. Fair enough.
• 4:05
  What about expenses that went down? Were there savings anywhere?
• 4:08
  Yes, and this is where some of the operational cleanup seems to be paying off.
• 4:12
  A few key areas saw decreases.
• 4:15
  Depreciation of property, plant, and equipment that dropped quite a bit from
• 4:18
  S$3,000 down to less than S$1,000.
• 4:21
  The reason given is just assets being fully depreciated or written off last year.
• 4:26
  Sort of an accounting effect. Okay, less old stuff to depreciate. Then finance costs.
• 4:30
  Good news here, they fell 38% from S$37,000 to S$23,000.
• 4:35
  That's mainly lower interest expense because they've been paying down various
• 4:39
  debts, borrowings, bill payables, lease liabilities.
• 4:42
  Paying down debt, saving on interest. Always a good sign for financial health. What else?
• 4:46
  Other operating expenses saw a really significant drop, down 40 percent from
• 4:51
  $2.3 million to Cervite $2 million.
• 4:54
  That's a S-100,000 saving right there. OK, that's a big chunk.
• 4:57
  That must have helped the bottom line quite a bit.
• 5:00
  What drove that decrease? Was it one thing or several?
• 5:03
  It was several specific things, mostly related to shedding the old metal business
• 5:07
  and some system changes.
• 5:08
  The report breaks it down pretty clearly.
• 5:11
  First, about S$31,000 less in computer costs because they switched accounting
• 5:16
  systems from something called Epicor to Xero. Hmm.
• 5:19
  Maybe Xero is cheaper or the transition costs from last year are gone. Could be.
• 5:24
  Then about $920,000 saved on rent because their TS medical operations starped.
• 5:30
  Ah, shutting down a non-core or perhaps underperforming part. Seems like it.
• 5:35
  Also, they didn't have these one-off professional fees anymore,
• 5:39
  about $12K a month last year, that were related to implementing a big ERP system
• 5:43
  after selling the metal business. Those fees are just,
• 5:46
  gone now. So past transition costs dropping off the books. Exactly.
• 5:49
  And finally, they also didn't have some partial one-off legal fees from last
• 5:53
  year related to a claim by a former executive from the old metal business. Right. So it's a mix.
• 5:58
  System efficiencies, shutting down operations, and crucially,
• 6:01
  just the absence of one-off costs tied to that big restructuring and divestment they did.
• 6:06
  Precisely. It really shows them tidying up the loose ends from the past,
• 6:10
  and that's flowing through to lower operating expenses now. That makes a lot of sense.
• 6:14
  But hang on, even with these improvements in the continuing operations,
• 6:18
  the healthcare side, was that enough on its own to explain that massive 67%
• 6:23
  drop in the overall loss?
• 6:25
  Or is there another piece to this puzzle? That's a really crucial point.
• 6:28
  No, the improvement isn't just from the current healthcare business getting better.
• 6:32
  A huge part of that overall loss reduction comes from something that isn't there
• 6:35
  anymore. Ah, the discontinued operations.
• 6:38
  Exactly. The loss from discontinued operations. In Q1 2024, they booked a sin
• 6:44
  $0.4 million loss related to disposing of those metal business subsidiaries.
• 6:49
  Since that whole disposal was finished in 2024, that entire $6.4 million loss
• 6:55
  line just vanishes from the Q1 2025 results.
• 6:58
  Got it. So that big 67% improvement headline number, you really need to see it as a combination.
• 7:03
  Better performance in the ongoing
• 7:04
  healthcare business? Driven by the acquisition and some cost control.
• 7:08
  PLUS. The simple fact that the big losses from the business they sold off are
• 7:11
  no longer dragging down the total result.
• 7:13
  That's the complete picture, yes. You need both sides of that story.
• 7:16
  Okay, that clarifies the profit and loss picture.
• 7:18
  Let's shift gears now and look at their financial position. The balance sheet.
• 7:23
  How did things look comparing the end of March 2025 to the end of last year, December 2024?
• 7:30
  All right, looking at the balance sheet snapshot, there are some definitely
• 7:33
  positive movements here for the group overall.
• 7:35
  Total assets went up from S1.6 million dollars to S2.0 million dollars.
• 7:40
  Assets up. Good start. What about liabilities?
• 7:43
  Total liabilities went down from S3.3 million dollars to S2.6 million dollars.
• 7:48
  Okay, assets up, liabilities down.
• 7:51
  That sounds like, well, like things are moving in the right direction,
• 7:54
  doesn't it? A stronger position. Relatively speaking, yes, it definitely points towards improvement.
• 7:58
  And importantly, this shows up in their net liabilities position.
• 8:01
  Remember, net liabilities means total debts exceed total assets.
• 8:05
  For the group, that net liability figure improved dramatically.
• 8:08
  It decreased from S1.7 million dollars down to C.6 million dollars.
• 8:12
  Same improvement for net current liabilities, too.
• 8:15
  Wow, that's a really significant reduction in that negative equity hole,
• 8:18
  even if they haven't quite climbed out of it yet.
• 8:20
  What were the key moving parts in assets and liabilities that caused that shift? Okay, on the asset side.
• 8:25
  Trade and other receivables ticked up slightly. S1.0 million dollars to S1.1 million dollars.
• 8:30
  Interestingly, the report notes that S1.0 million dollars of this is a GST mount
• 8:35
  they expect to recover from Malaysian customs.
• 8:39
  A large receivable like that is always something to watch, but the state management
• 8:43
  believes it's recoverable. They do.
• 8:45
  Pre-payments also went up a bit, $6,000 to $21,000 for things like insurance
• 8:49
  paid up front, nothing major there.
• 8:51
  But the really key change on the asset side, especially given the context,
• 8:55
  is cash and bank balances.
• 8:57
  That jumped significantly, went from S-100, $187,000 at year end to $535,000 at the end of March.
• 9:04
  Okay, nearly triple the cash on hand. That's a very positive sign,
• 9:07
  particularly with that going concern shadow lurking.
• 9:10
  What about the liability side? What drove the decrease there?
• 9:13
  Mostly debt repayment. Total borrowings fell from S2.1 million dollars to S1.7 million dollars.
• 9:19
  That's mainly paying down bank loans and bill payables. Lease liabilities also
• 9:23
  edged down 214k to 492k just for making lease payments.
• 9:27
  And trade and other payables, what they owe suppliers and others,
• 9:30
  saw a good drop too, from S1.0 million dollars down to S.7 million dollars.
• 9:35
  That reflects them settling outstanding bills. All right, so they're bringing
• 9:39
  cash in the door and using it strategically to pay down debt and settle bills.
• 9:43
  Which brings us nicely to the cash flow statement.
• 9:46
  This is often where you see the real action, the how behind those balance sheet changes.
• 9:50
  And here's where it gets really interesting, I think. How did they manage to
• 9:53
  boost their cash pile and cut liabilities while still technically posting an operating loss?
• 9:59
  Exactly. The cash flow statement tells that story, and it's quite a dramatic
• 10:02
  turnaround from last year.
• 10:03
  For these first three months of 2025, the group actually had a net cash inflow of about $0.3 million.
• 10:09
  Now compare that to Q1 2024. Back then, they had a net cash outflow of roughly S2.5 million dollars.
• 10:16
  Whoa, hang on. From burning through S2.5 million dollars to actually bringing
• 10:20
  in 633 million dollars, that's a swing of almost S3 million dollars in cash
• 10:25
  flow between the two quarters.
• 10:26
  That's huge. Where did that positive cash flow come from? Well,
• 10:29
  and this is where it gets a bit counterintuitive at first glance.
• 10:31
  It didn't come from operations this quarter.
• 10:33
  In fact, net cash used in operating activities actually increased slightly.
• 10:38
  The outflow went from $0.6 million in Q1 2024 to $6.7 million in Q1 2025.
• 10:45
  Wait, stop. Cash used in operations went up. They used more cash,
• 10:48
  but we just talked about how their operating loss went down significantly. That seems backwards.
• 10:52
  How can they use more cash if the operations are performing better loss-wise?
• 10:54
  That's a great question. And it really highlights why looking only at profit
• 10:58
  or loss doesn't tell the whole cash story.
• 11:00
  It's about working capital changes, too.
• 11:03
  The report explains that this SSEC-T4 $7 million operating cash outflow wasn't
• 11:08
  just from the operating loss itself. It was the loss plus a significant outflow
• 11:12
  from working capital changes.
• 11:14
  Specifically, it was mainly driven by that decrease in trade and other payables
• 11:19
  we saw on the balance sheet.
• 11:20
  Remember how they paid down about $300 of what they owed? Ah, all right.
• 11:25
  Paying off those old bills uses up cash, even if the underlying business is
• 11:29
  losing less money, period over period. Exactly.
• 11:32
  So they made a conscious decision to use cash to clean up those payables on the balance sheet.
• 11:37
  That action, while good for the balance sheet, resulted in a higher cash outflow
• 11:42
  from operations in this specific quarter, despite the improved operating loss
• 11:46
  figure on the income statement.
• 11:47
  Okay, that makes sense now. They spent cash to improve their liability position.
• 11:51
  So if operations actually used more cash this quarter, where on earth did that
• 11:55
  overall positive net cash inflow of $2.3 million come from? It had to come from somewhere else.
• 12:02
  It came overwhelmingly from financing activities. That's the key driver.
• 12:06
  In Q1 2025, net cash generated from financing activities was approximately S1.0
• 12:12
  million dollars, a million dollars in from financing.
• 12:15
  Contrast that with Q1 2024, where they actually use 0.3 million dollars in financing
• 12:20
  activities. So a massive turnaround there, too.
• 12:23
  OK, financing was the hero this quarter. And what was the main source of that
• 12:27
  S1.0 million dollar cash injection from financing? The big item was proceeds
• 12:32
  from issuing new shares.
• 12:33
  About $01.4 million came in from the rights issue they completed back in February 2025.
• 12:38
  The rights issue. Right. Shareholders put more money in. Precisely.
• 12:41
  That big chunk of cash came in.
• 12:43
  There were also some smaller proceeds from new borrowings, about $0.3 million.
• 12:47
  But that was largely offset by repayments of other borrowings and lease liabilities,
• 12:51
  which totaled about $0.7 million going out, plus the interest paid of $23K.
• 12:55
  So you net all that financing activity out, the big share issuance,
• 12:59
  some new debt, paying off old debt, and you end up with that positive S1.2 million
• 13:04
  dollar inflow from financing.
• 13:05
  And there it is. That S1.0 dollar financing inflow more than covered the C.7
• 13:11
  million dollar operating outflow,
• 13:13
  leaving them with that net 0.3 million dollar cash increase overall,
• 13:17
  which explains how their cash balance grew from roughly 2.2 million dollars
• 13:21
  to over 2.5 million dollars during the quarter.
• 13:24
  That rights issue was clearly critical. Absolutely critical.
• 13:28
  It plugged the operating cash gap and allowed them to strengthen the balance
• 13:31
  sheet by paying down some debt.
• 13:33
  It bought them breathing room. Let's circle back then to that material uncertainty
• 13:37
  related to going concern that started our conversation.
• 13:40
  How does this Q1 report and the context they provide address that specific point from the auditors?
• 13:45
  Well, the financial statements themselves are still prepared on a going concern basis.
• 13:50
  Management believes the company can continue. But importantly,
• 13:53
  the report doesn't shy away from the uncertainty. It explicitly lists the reasons
• 13:57
  why the directors feel comfortable using that going concern assumption,
• 14:00
  at least for the next 12 months from early April 2025.
• 14:04
  And what are those key reasons they list? There are four main points they highlight.
• 14:08
  One, they're continuing to implement cost reduction strategies,
• 14:11
  actively managing expenses.
• 14:13
  Two, they've negotiated a revised longer payment plan for that GST amount owed
• 14:18
  to Malaysian Customs, which helps short-term cash flow.
• 14:21
  Three, they're taking legal action regarding some past irregularities in a company
• 14:26
  called Gain Health Pete LTD, specifically going after individuals involved,
• 14:31
  trying to recover funds, perhaps.
• 14:33
  Okay, operational improvements, managing liabilities, addressing past issues.
• 14:36
  What's the fourth? The fourth is probably the most significant from an external
• 14:41
  assurance perspective.
• 14:43
  They have an undertaking from a controlling shareholder. This shareholder has
• 14:46
  committed to provide continuing financial support to the group,
• 14:49
  if needed, for up to 12 months from April 2nd, 2025.
• 14:53
  Ah, that's a big one. A shareholder backstop. Auditors often look for things
• 14:57
  like that when assessing going concern. It provides a potential safety net. Exactly.
• 15:01
  It's a crucial piece of evidence supporting management's assertion that they
• 15:04
  can meet their obligations for the foreseeable future despite the current financial position.
• 15:09
  And speaking of financial support, that rights issue we established was so important,
• 15:13
  bringing about S1.43 million dollars after costs.
• 15:17
  How exactly did they say they used that money as of the report date?
• 15:21
  They give a pretty clear breakdown.
• 15:23
  Out of the S1.43 million dollar net proceeds, S992,000 dollars went towards repaying loans.
• 15:31
  S-640,000 was used for general corporate and working capital purposes.
• 15:36
  Okay, so nearly a million straight to debt reduction. What about the working
• 15:38
  capital bit? Any more detail there? Yes, they break down that S-640K.
• 15:43
  About 26K covered employee benefits expenses.
• 15:46
  The bulk, 614K, went towards things like legal and professional fees,
• 15:50
  rent, and other general corporate expenses.
• 15:53
  That left about S-250,000 of the rights-issue proceeds still unused at the time
• 15:58
  of the announcement. Right.
• 15:59
  So primarily use it to chip away at debt and just keep the lights on,
• 16:03
  funding those ongoing operating costs, buys them time and improves the balance sheet health somewhat.
• 16:07
  So what's the outlook? What does Med-Am Health say about the road ahead?
• 16:10
  Their stated focus looking forward is very much on growth through acquisition.
• 16:14
  They want to identify new businesses, potential M&A targets to really build
• 16:20
  up the group's revenue streams now that the metal business is fully gone.
• 16:23
  Okay. Actively looking for deals.
• 16:25
  Yes. And interestingly, they suggest that the current global economic climate
• 16:29
  trade tensions, macroeconomic uncertainties, might actually create opportunities.
• 16:34
  They think it may allow them to acquire quality assets at reasonable valuations. Huh.
• 16:40
  That's a potentially contrarian view, seeing opportunity in uncertainty.
• 16:44
  Trying to buy when others might be struggling or hesitant. It is an interesting strategic stance.
• 16:50
  However, they immediately follow that with a note of caution about their existing business.
• 16:54
  They forecast potential margin erosion for their current operating clinic,
• 16:58
  the jazz medical part. Margin erosion. Why?
• 17:00
  They attribute it to rising costs from their suppliers, which they see as being
• 17:04
  driven by those same prevailing global macroeconomic uncertainties.
• 17:09
  So inflation hitting their input costs. Ah, okay.
• 17:12
  So, hunting for new growth via acquisition, but simultaneously brazing for profitability
• 17:18
  pressure in the business they just bought due to rising costs.
• 17:22
  Bit of a push-pull there. And unsurprisingly, given the loss they reported,
• 17:25
  they state that no dividend has been recommended for this period. Makes sense.
• 17:29
  Can't really pay dividends when you're loss-making and focused on shoring up
• 17:33
  the finances. So, stepping back, if you've been following MetaHealth.
• 17:37
  What does this whole deep dive into their Q1 report really tell you?
• 17:41
  I think it clearly shows a company in the midst of a significant turnaround
• 17:45
  effort, facing that serious going concern issue head on.
• 17:49
  You see the direct impact of their strategic decisions.
• 17:52
  Selling the old business stopped those losses. Buying the new one boosted revenue.
• 17:56
  The rights issue brought in vital cash. They're actively using that cash to
• 18:00
  manage costs, pay down debt, settle bills. And the result, this quarter at least,
• 18:04
  is a much reduced overall loss, higher revenue, improved net liabilities,
• 18:09
  and crucially, more cash in the bank.
• 18:11
  It really demonstrates that even in a tough spot, focused actions across operations,
• 18:16
  finance, and strategy can move the needle on key financial metrics, right?
• 18:21
  At least in the short term. Definitely. It shows management pulling specific
• 18:25
  levers, divestment, acquisition, capital raising, debt reduction.
• 18:28
  You see the cause and effect playing out in the numbers. It goes beyond just
• 18:32
  the headline loss figure.
• 18:33
  It's about how they achieve that change. Absolutely.
• 18:37
  Understanding the components of the change is key.
• 18:40
  Okay, so to quickly recap the main points for everyone listening.
• 18:44
  MetaHealth showed a big improvement in Q1 2025.
• 18:47
  They cut their reported loss by two-thirds, mainly by getting rid of losses
• 18:51
  from the old metal business and getting new revenue from the Jays' medical acquisition. Right.
• 18:56
  They also significantly improved their cash position, going from a large outflow
• 19:01
  last year to a small inflow this year, thanks almost entirely to raising capital
• 19:05
  from shareholders via that rights issue.
• 19:07
  And they use some of that cash to pay down debt, strengthening the balance sheet
• 19:11
  somewhat. But the flip side is important, too.
• 19:15
  They're still making an operating loss in their current business.
• 19:18
  They still have more liabilities than assets overall,
• 19:21
  net liabilities, and that material uncertainty regarding going concern still
• 19:27
  formally exists even if management has a plan and shareholder support. Precisely.
• 19:31
  The improvement is notable, but the underlying challenges haven't vanished overnight.
• 19:36
  And looking ahead, their strategy seems twofold.
• 19:39
  Actively hunt for more acquisitions to build scale, possibly taking advantage of market uncertainty.
• 19:44
  While also acknowledging that their existing core business might face shrinking
• 19:48
  margins because of rising costs, also linked to that same market uncertainty.
• 19:53
  Which leads to a really interesting thought to leave you with,
• 19:55
  building on that outlook.
• 19:56
  Yeah, the question becomes, How does a company in this position successfully
• 20:01
  balance those two things?
• 20:02
  The aggressive pursuit of growth through potentially costly acquisitions,
• 20:06
  while simultaneously needing to manage costs tightly and protect profitability
• 20:10
  in their current operations, especially if those macro headwinds pick up.
• 20:15
  That's the tightrope they have to walk.
• 20:16
  Finding growth versus managing the bottom line in uncertain times.
• 20:20
  Definitely something to watch.
• 20:22
  Music.